{"id":"phenprobamate","rwe":[],"tags":[{"label":"phenprobamate","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"M03BA01","category":"atc"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"ansepron","offLabel":[],"synonyms":["phenprobamate","3-Phenylpropyl carbamate","ansepron","proformiphen"],"timeline":[],"approvals":[],"brandName":"Ansepron","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"phenprobamate","explanation":"Think of neurotransmitters like messengers that help different parts of the brain talk to each other. Ansepron helps regulate the activity of these messengers, which can help calm down overactive brain signals that may be causing anxiety or other symptoms. By doing so, it can help restore balance to the brain's communication system.","oneSentence":"Ansepron works by modulating the activity of certain neurotransmitters in the brain.","technicalDetail":"Phenprobamate is a GABA_A receptor modulator, which means it affects the activity of a type of receptor that helps regulate the activity of inhibitory neurotransmitters like GABA."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2137","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=PHENPROBAMATE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:19:13.991471","biosimilars":[],"competitors":[{"drugName":"carisoprodol","drugSlug":"carisoprodol","fdaApproval":"1959-04-09","genericCount":22,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"methocarbamol","drugSlug":"methocarbamol","fdaApproval":"1957-07-16","patentExpiry":"Oct 9, 2044","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"phenprobamate","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"carisoprodol","brandName":"carisoprodol","genericName":"carisoprodol","approvalYear":"1959","relationship":"same-class"},{"drugId":"methocarbamol","brandName":"methocarbamol","genericName":"methocarbamol","approvalYear":"1957","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"UJZ473TPS0","CHEBI":"CHEBI:31992","INN_ID":"892","UMLSCUI":"C0070591","ChEMBL_ID":"CHEMBL1079576","KEGG_DRUG":"D01824","DRUGBANK_ID":"DB13354","PUBCHEM_CID":"4770","MESH_SUPPLEMENTAL_RECORD_UI":"C008837"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Neuroscience"],"atcClassification":{"source":"DrugCentral","atcCode":"M03BA01","allCodes":["M03BA01","M03BA51","M03BA71"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ansepron is a small molecule with the synonyms FENPROBAMATO, MH-532, NSC-44682, NSC-50538, NSC-64270, and PHENPROBAMATE.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}